Obesity Does Not Alter RALP Outcomes, Study Shows

June 2010
Renal & Urology News;Jun2010, Vol. 9 Issue 6, p32
The article reports on the findings of a study regarding the association of obesity and the outcomes of robotic-assisted laparoscopic prostatectomy (RALP) in patients with prostate cancer in the U.S.


Related Articles

  • Five-Year RARP Outcomes Are 'Highly Satisfactory,' Researchers Conclude.  // Renal & Urology News;May2011, Vol. 10 Issue 5, p15 

    The article focuses on the results of the five-year oncologic outcomes of robot-assisted radical prostatectomy (RARP) for patients with organ-confined localized prostate cancer (PCa) as studied by the research team led by doctor Nazareno Suardi.

  • Radiotherapy after prostatectomy increased PFS in pT3 prostate cancer. Adams, Stacey L.; Haigh, Christen; Harris, Jason; Lewis, Jay; Southall, Jen; Volansky, Rob // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p38 

    The article discusses research on the effect of radiotherapy after prostatectomy on progression-free survival (PFS) in pT3 prostate cancer patients, which references a study by J. Wiegel published in a 2009 issue of the "Journal of Clinical Oncology."

  • Metastasis, Obesity Linked in PCa Patients on ADT. Charnow, Jody A. // Renal & Urology News;Jan2012, Vol. 11 Issue 1, p20 

    The article reports on the findings of a retrospective study of prostate cancer (PCa) patients conducted by a group of researchers led by Christopher Keto of Duke University Medical Center in Durham, North Carolina and Stephen J. Freedland of Duke Prostate Center. The study shows that obesity is...

  • Impotence is not inevitable after prostate cancer treatment. McCann, Jean // JNCI: Journal of the National Cancer Institute;02/05/97, Vol. 89 Issue 3, p194 

    Focuses on prostate cancer patients' recovery of sexual functions after undergoing nerve-sparing radical prostatectomy. Surgeon D. Karl Montague's report on guidelines for the treatment of impotence or erectile dysfunction; 1996 World Meeting on Impotence; Surgical options for restoring erectile...

  • PCa Death Risk Low Despite PSM.  // Renal & Urology News;Jun2012, Vol. 11 Issue 6, p31 

    The article reports on a study which revealed that prostate cancer (PCa) patients has a positive surgical margin (PSM) in their radical prostatectomy specimen has a low risk of cancer-related death and systemic progression.

  • Short Takes.  // Renal & Urology News;Apr2010, Vol. 9 Issue 4, p9 

    The article offers news briefs related to medical research including a study on kidney cancer which less probably to develop in men whose work expose them to sunlight, another study on prostate cancer patients having prostate-cancer survival after radical prostatectomy and a study on acute...

  • Metastasis-Free Interval Affects PCa Patient Survival.  // Renal & Urology News;Oct2013, Vol. 12 Issue 10, p15 

    The article reports on the study conducted by Michael T. Schweizer and colleagues at Johns Hopkins University in Baltimore which suggests that longer metastasis-free survival predicts overall survival in men who experience biochemical recurrence of prostate cancer (PCa) after radical prostatectomy.

  • Widespread adoption of Robot-Assisted Cancer Surgery to remove the prostate.  // Pulse International;9/15/2014, Vol. 15 Issue 17, p7 

    The article focuses on a study at Harvard Medical School, the Dana-Farber Cancer Institute and Brigham and Women's Hospital published in "British Journal of Urology International" which indicated the use of robotic-assisted radical prostatectomy surgical procedure for patients with prostate cancer.

  • The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer. Kuzgunbay, Barış; Yaycıoğlu, Özgür // Journal of Urological Surgery;Sep2015, Vol. 2 Issue 3, p120 

    High-risk prostate cancer (PCa), which is defined as PSA >20 ng/mL or Gleason Score (GS) >7 or ≥cT3a, accounts for up to 40% of newly diagnosed cases and carries a significant risk of progression and death. However, the best management approach for patients with high-risk PCa is still...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics